MicroStrategy $60.5 million tender offer
Davis Polk advised the dealer manager in connection with a “modified Dutch auction” cash tender offer by MicroStrategy Incorporated for 432,313 of its shares of common stock at a purchase…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion,…
Victoria’s Secret separation from L Brands in a transaction with Sycamore
We are advising L Brands on the separation of Victoria’s Secret
Brookfield $13.2 billion acquisition of Johnson Controls’ Power Solutions unit
Davis Polk is advising Brookfield Business Partners L.P. on its $13.2 billion acquisition of the Power Solutions business of Johnson Controls International plc. The transaction is expected…
SUEZ $601 million sale of 20% of Suez Water Resources to PGGM
Davis Polk is advising SUEZ S.A. on its $601 million sale of 20% of SUEZ Water Resources Inc. to PGGM. The transaction is expected to be completed by the first half of 2019, subject to…
Davis Polk Advises Williams on Its Acquisition of All the Public Equity of Williams Partners
Davis Polk is advising Williams on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners L.P. in an all stock-for-unit transaction at a 1.494…
SS&C Technologies $5.4 billion acquisition of DST Systems
Davis Polk is advising SS&C Technologies Holdings, Inc. on its approximately $5.4 billion acquisition of DST Systems, Inc. The transaction, which is expected to close by the third…
Davis Polk Advises CSX on Its Agreement with Mantle Ridge
Davis Polk is advising CSX Corporation in connection with an agreement with Mantle Ridge LP to reconstitute CSX’s board of directors. Under the terms of the agreement, CSX has appointed…
Davis Polk Advises Roche on Its Sale of Florence, South Carolina, Manufacturing Site to Patheon
Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, to Patheon N.V. Under the…
Davis Polk Advises Atairos Group on Its Acquisition of Learfield
Davis Polk is advising Atairos Group, Inc. on its acquisition of Learfield Communications, Inc. from Providence Equity Partners and other shareholders. Financial terms of the transaction…